SCHEMBL22919765

SCHEMBL22919765

Nc1nc2cc(C(=O)Nc3ccc(Cl)c(Cl)c3)ccc2n1CCCc1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EHMT2 Q96KQ7 2/20 0.56
▸ EHMT1 Q9H9B1 1/20 0.56
▸ BACE1 P56817 1/20 0.50
▸ MEN1 O00255 2/20 0.49
▸ MAPT P10636 2/20 0.49
▸ KMT2A Q03164 2/20 0.49
▸ HTT P42858 1/20 0.49
▸ IRAK4 Q9NWZ3 1/20 0.48
▸ HDAC1 Q13547 1/20 0.48
▸ HDAC8 Q9BY41 1/20 0.48
▸ MAOB P27338 4/20 0.48
▸ MAOA P21397 3/20 0.48
▸ ACHE P22303 1/20 0.48
▸ PPARG P37231 5/20 0.48
▸ ADORA2A P29274 1/20 0.47
▸ NPC1 O15118 2/20 0.46
▸ RAB9A P51151 2/20 0.46
▸ PRMT1 Q99873 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ PKM P14618 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL21437347 0.99 EHMT2 (0.55) EHMT2EHMT1BACE1MEN1MAPT
SCHEMBL22919755 0.96 EHMT2 (0.54) EHMT2EHMT1BACE1MEN1MAPT
Hydrochloric Acid SCHEMBL21437364 0.95 EHMT2 (0.53) EHMT2EHMT1BACE1MEN1MAPT
SCHEMBL26451918 0.90 EHMT2 (0.52) EHMT2EHMT1BACE1MEN1MAPT
SCHEMBL26451963 0.90 BACE1 (0.52) EHMT2EHMT1BACE1MEN1MAPT
Hydrochloric Acid SCHEMBL21437392 0.89 BACE1 (0.52) EHMT2EHMT1BACE1MEN1MAPT
SCHEMBL21450755 0.87 BACE1 (0.54) EHMT2EHMT1BACE1HDAC1HDAC8
Hydrochloric Acid SCHEMBL21437366 0.86 BACE1 (0.53) EHMT2EHMT1BACE1HDAC1HDAC8
SCHEMBL21450840 0.85 BACE1 (0.46) EHMT2EHMT1BACE1MEN1MAPT
Hydrochloric Acid SCHEMBL21437257 0.84 EHMT2 (0.53) EHMT2EHMT1BACE1MEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230138583-A1 SUBSTITUTED 2-AMINOBENZIMIDAZOLES ANALOGS AS ANTIBIOFILM AGENTS OHIO STATE INNOVATION FOUNDATION 2023-05-04 — — US disclosed
US-20210023060-A1 SUBSTITUTED 2-AMINOBENZIMIDAZOLES ANALOGS AS ANTIBIOFILM AGENTS NORTH CAROLINA STATE UNIVERSITY 2021-01-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210023060-A1 SUBSTITUTED 2-AMINOBENZIMIDAZOLES ANALOGS AS ANTIBIOFILM AGENTS ITGB3, ITGB2, ITGAM EHMT2 1620/4885EHMT1 2401/4885BACE1 2983/4885
US-20230138583-A1 SUBSTITUTED 2-AMINOBENZIMIDAZOLES ANALOGS AS ANTIBIOFILM AGENTS ITGB3, ITGB2, ITGAM EHMT2 1620/4885EHMT1 2401/4885BACE1 2983/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback